Investigator-Initiated Studies Program

Your research ideas. Our innovative technologies.

Ceribell is used in 600+ hospitals nationwide and has helped them manage the care of 250,000+ emergency and critical care patients.


The Ceribell Investigator-Initiated Studies (IIS) Program supports clinically meaningful research investigating the effects of rapid EEG and AI-assisted neurologic monitoring on patient outcomes, workflow efficiency, and clinical decision-making. The program also supports resident- and fellow-led projects that are feasible within typical training timelines.

Areas of Focus

All submissions are evaluated on scientific rigor, feasibility, and overall alignment with Ceribell’s strategic areas of focus. For the year 2026, we particularly encourage submissions aiming to investigate the clinical and economic effect of Ceribell technologies in the following settings:

  • Pediatric and neonatal seizures
  • Critically ill patients at risk for seizure without primary acute neurological injury (e.g. sepsis) 
  • Seizure detection and monitoring workflows in the emergency department
  • Delirium in adults with critical illness or following major surgery
  • Neurovascular diseases (e.g. stroke) 

Funding & Support

Support may include device access, analytic resources, and other infrastructure support. Modest funding for study costs may be available up to $50,000 per study commensurate with project scope. Funding tiers are as follows:

  • Tier 1: device support (70% of accepted proposals)
  • Tier 2: device support plus $10-20,000 per study (20% of accepted proposals)
  • Tier 3: device support plus up to $50,000 per study (10% of accepted proposals)

Recent peer-reviewed publications from IIS supported by Ceribell

  • Vattipally V.N., et al. (2026) Point-of-care electroencephalography for prediction of postoperative delirium in older adults undergoing elective surgery: protocol for a prospective cohort study. Biology Methods & Protocols, 11(1), bopaf093. https://doi.org/10.1093/biomethods/bpaf093
  • Desai, M., et al. (2025) Evaluating the Impact of Point-of-Care Electroencephalography on Length of Stay in the Intensive Care Unit: Subanalysis of the SAFER-EEG Trial. Neurocrit Care. 42(1),108–117. https://doi.org/10.1007/s12028-024-02039-6
  • Kalkach-Aparicio M., et al. (2024) Seizure Assessment and Forecasting With Efficient Rapid-EEG: A Retrospective Multicenter Comparative Effectiveness Study. Neurology. 103(2):e209621. https://doi.org/10.1212/WNL.0000000000209621